Date | Time | Source | Headline | Symbol | Company |
06/20/2024 | 1:41AM | Alliance News | Japan "seriously concerned" over Putin's North Korea treaty | | |
06/20/2024 | 1:38AM | Alliance News | LONDON MARKET EARLY CALL: FTSE 100 called higher before BoE decision | | |
06/20/2024 | 1:33AM | Alliance News | GET READY: CMC Markets, Cordiant, DS Smith, XPS Pensions at 0700 BST | | |
06/20/2024 | 1:33AM | GlobeNewswire Inc. | Vallourec extends its contract with the National Oil Company of Abu Dhabi and wins a new order | | |
06/20/2024 | 1:33AM | GlobeNewswire Inc. | Vallourec prolonge son contrat avec la compagnie pétrolière nationale d'Abu Dhabi et remporte une nouvelle commande | | |
06/20/2024 | 1:33AM | GlobeNewswire Inc. | Vallourec extends its contract with the National Oil Company of Abu Dhabi and wins a new order | EU:VK | Vallourec |
06/20/2024 | 1:33AM | PR Newswire (US) | Envision Energy Launches Advanced 5 MWh Container Battery Energy Storage System with Industry-Leading Safety Standards | | |
06/20/2024 | 1:32AM | PR Newswire (Canada) | More Economical, More Space, More Power - GAC EMZOOM Redefining Innovation on Global SUV Market | | |
06/20/2024 | 1:32AM | PR Newswire (US) | More Economical, More Space, More Power - GAC EMZOOM Redefining Innovation on Global SUV Market | | |
06/20/2024 | 1:30AM | Alliance News | Alliance News UK - start of day | | |
06/20/2024 | 1:30AM | GlobeNewswire Inc. | Sampo plc’s share buybacks 19 June 2024 | | |
06/20/2024 | 1:30AM | GlobeNewswire Inc. | OSE Immunotherapeutics présente des données précliniques sur sa plateforme ARNm thérapeutique dans le traitement des maladies auto-immunes et inflammatoires au congrès annuel FOCIS, San Francisco (18 – 21 juin) | TG:6OP | OSE Immunotherapeutics |
06/20/2024 | 1:30AM | Business Wire | Sensorion Announces Upcoming Presentation of Promising SENS-401 Results at the Next International Conference on Cochlear Implants and Other Implantable Technologies | EU:ALSEN | Sensorion |
06/20/2024 | 1:30AM | GlobeNewswire Inc. | OSE Immunotherapeutics présente des données précliniques sur sa plateforme ARNm thérapeutique dans le traitement des maladies auto-immunes et inflammatoires au congrès annuel FOCIS, San Francisco (18 – 21 juin) | LSE:0RAD | Ose Immunotherapeutics Sa |
06/20/2024 | 1:30AM | GlobeNewswire Inc. | OSE Immunotherapeutics présente des données précliniques sur sa plateforme ARNm thérapeutique dans le traitement des maladies auto-immunes et inflammatoires au congrès annuel FOCIS, San Francisco (18 – 21 juin) | EU:OSE | OSE Immunotherapeutics |
06/20/2024 | 1:30AM | GlobeNewswire Inc. | BGHL (GBP): NAV(s) | LSE:BGHS | Boussard & Gavaudan Holding Limited |
06/20/2024 | 1:30AM | GlobeNewswire Inc. | OSE Immunotherapeutics Presents Preclinical Data on mRNA Therapeutic Platform for the Treatment of Inflammatory and Autoimmune Disorders at the FOCIS Annual Meeting, San Francisco (June 18 – 21) | EU:OSE | OSE Immunotherapeutics |
06/20/2024 | 1:30AM | GlobeNewswire Inc. | BGHL (GBP): NAV(s) | EU:BGHS | Boussard and Gavaudan Holding |
06/20/2024 | 1:30AM | GlobeNewswire Inc. | OSE Immunotherapeutics Presents Preclinical Data on mRNA Therapeutic Platform for the Treatment of Inflammatory and Autoimmune Disorders at the FOCIS Annual Meeting, San Francisco (June 18 – 21) | TG:6OP | OSE Immunotherapeutics |
06/20/2024 | 1:30AM | GlobeNewswire Inc. | BGHL (EUR): NAV(s) | EU:BGHL | Boussard And Gavaudan Holding Limited |
06/20/2024 | 1:30AM | GlobeNewswire Inc. | BGHL (EUR): NAV(s) | LSE:BGHL | Boussard & Gavaudan Holding Limited |
06/20/2024 | 1:30AM | Business Wire | Sensorion annonce la présentation de résultats prometteurs du SENS-401 lors de la prochaine Conférence Internationale sur les Implants Cochléaires et autres Technologies Implantables | EU:ALSEN | Sensorion |
06/20/2024 | 1:30AM | GlobeNewswire Inc. | OSE Immunotherapeutics Presents Preclinical Data on mRNA Therapeutic Platform for the Treatment of Inflammatory and Autoimmune Disorders at the FOCIS Annual Meeting, San Francisco (June 18 – 21) | LSE:0RAD | Ose Immunotherapeutics Sa |
06/20/2024 | 1:30AM | GlobeNewswire Inc. | OSE Immunotherapeutics Presents Preclinical Data on mRNA Therapeutic Platform for the Treatment of Inflammatory and Autoimmune Disorders at the FOCIS Annual Meeting, San Francisco (June 18 – 21) | EU:OSE | OSE Immunotherapeutics |
06/20/2024 | 1:21AM | Alliance News | TOP NEWS: China's central bank leaves loan prime rates unmoved | | |
06/20/2024 | 1:15AM | GlobeNewswire Inc. | Basilea partners oncology drug candidate lisavanbulin with Glioblastoma Foundation | | |
06/20/2024 | 1:00AM | Business Wire | Mon Courtier Energie Groupe Announces the Approval of All Resolutions Supported by the Board of Directors at its Annual General Meeting | EU:ALMCE | Mon Courtier Energie Groupe SA |
06/20/2024 | 1:00AM | GlobeNewswire Inc. | Avextra AG and SynQube GmbH announce a Strategic Partnership in Drug Development with Cannabinoids and other Psychotropic Substances | | |
06/20/2024 | 1:00AM | GlobeNewswire Inc. | Start of Day Message | | |
06/20/2024 | 1:00AM | Business Wire | Mon courtier énergie groupe annonce l’approbation de l’ensemble des résolutions soutenues par le Conseil d’administration lors de son assemblée générale | EU:ALMCE | Mon Courtier Energie Groupe SA |